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Protein disulfide isomerase (PDI), is a member of the thioredoxin superfamily of redox
proteins. PDI has three catalytic activities including, thiol-disulfide oxireductase, disulfide
isomerase and redox-dependent chaperone. Originally, PDI was identified in the lumen
of the endoplasmic reticulum and subsequently detected at additional locations, such
as cell surfaces and the cytosol. This review will provide an overview of the recent
advances in relating the structural features of PDI to its multiple catalytic roles as well as
its physiological and pathophysiological functions related to redox regulation and protein
folding.
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INTRODUCTION
In 1963, microsomal preparations of rat liver were shown to
reactivate reduced ribonuclease A (Goldberger et al., 1963). The
enzyme that catalyzed this reaction was eventually identified as
protein disulfide isomerase (PDI; EC 5.3.4.1). PDI is one of
20 proteins belonging to the PDI family (Kozlov et al., 2010).
The proteins in this family all contain at least one domain with
a thioredoxin-like fold(βαβαβαββα), but may vary in length and
domain arrangement (Kozlov et al., 2010).
Edman and coworkers were able to determine the active site
sequence of rat PDI as WCGHCK through sequencing of cDNA
(Edman et al., 1985). This sequence was homologous to the
active site of thioredoxin and was found to catalyze the reduc-
tion and isomerization of disulfide bonds and the oxidation of
thiols (Figure 1) (Holmgren, 1968). In 1994 Cai and cowork-
ers discovered PDI also had chaperone activity in addition to
its redox activity (Cai et al., 1994). In 1998, McLaughlin and
Bulleid showed that the chaperone activity was independent of
the redox status of active site thiols (McLaughlin and Bulleid,
1998). The three catalytic activities of PDI, thiol redox, disulfide
exchange, and chaperone are central to endoplasmic reticulum
(ER) function (Maattanen et al., 2010).
PDI is expressed in almost all mammalian tissues (Marcus
et al., 1996; Noiva, 1999). Although PDI has a C-terminal KDEL
ER retention sequence, significant amounts of this protein were
shown to escape the ER and were detected in the nucleus, cytosol,
cell surface, and extracellularly (Edman et al., 1985; Koch, 1987;
Yoshimori et al., 1990).
This review will focus on recent discoveries on PDI structure-
function and physiological and pathophysiological roles arising
from its localization in tissues including hemostasis, facilitation of
pathogen entry, and reactive nitrogen and oxygen signaling. For
more information on the role PDI in cancer, lipid homeostasis,
infertility etc., the readers are directed to the reviews by Bulleid
and Ellgaard (2011), Andreu et al. (2012), Laurindo et al. (2012),
and Benham (2012).
PDI STRUCTURE
All members of the PDI family share the thioredoxin-like domain
structure characterized by the βαβαβαββα fold (Kemmink et al.,
1997). PDI contains four thioredoxin-like domains abb’a’. The
two redox active sites containing the CXXCmotif are found in the
a and a’ domains (Figure 2). The active site domains are linked
by the b and b’ domains. There is also a small interdomain region
known as the x-linker located between b’ and a’ (Freedman et al.,
1998; Alanen et al., 2003). For an in depth review on the structure
of PDI the reader is directed to a recent review by Kozlov et al.
(2010).
Recent advances in NMR and x-ray crystallography have given
further insight into PDI structure and function, by identifying the
b’ as the chaperone domain. Through NMR, the structure and
amino acid residues of the b’ domain were observed to interact
with unfolded RNase A, an oft used enzyme to assay the chap-
erone activity of PDI. The b’ domain contains a large multiva-
lent hydrophobic surface allowing for a structurally promiscuous
binding site (Denisov et al., 2009). In addition, computational
analysis indicates that the bb’ domains contain 4 cavities allowing
for the possible binding of a variety of ligands (see Section PDI
Chaperone Activity). Recently human PDI is observed to dimer-
ize in vivo through the binding of bb’ (Bastos-Aristizabal et al.,
2014).
PDI CHAPERONE ACTIVITY
The chaperone activity of PDI is an essential area of study to fur-
ther understand the protein folding related roles of PDI in the
ER as well as neuronal tissues (see Section PDI and Coagulation).
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FIGURE 1 | Redox reactions of PDI. (A) Oxidation and reduction. (B)
Isomerization.
Historically the chaperone activity of PDI was assessed by a
variety of methods depending on renaturation of denatured pro-
teins monitored by activity-gain or loss-of-aggregates (Shao et al.,
2000; Ben Khalaf et al., 2012; Wang et al., 2012; Hashimoto
and Imaoka, 2013). A recent addition to this list utilizes acid-
denatured green fluorescent protein (GFP), which interacts with
a chaperone protein like PDI, and refold to yield the proper con-
figuration and fluorescent properties (Mares et al., 2011). This
technology allows for a high-throughput assays for chaperone
activity and its inhibitors (Mares et al., 2011).
Recent work using NMR, indicated that PDI is able to distin-
guish between unfolded, partly folded, and fully folded proteins.
In these studies, it was observed that the dissociation constant
(KD) for fully unfolded basic pancreatic trypsin inhibitor was
∼1.5μM (Irvine et al., 2014). On the other hand the fully folded
protein had a KD that was∼10 fold higher. Partially unfolded pro-
tein had a KD that was∼3 fold higher. These data lead the authors
to conclude that PDI can distinguish between unfolded, partially
unfolded, and folded proteins (Irvine et al., 2014).
A major recent discovery shows that the chaperone activity of
PDI is regulated by its redox status. Wang and coworkers were
the first to obtain the crystal structure of human PDI in both the
reduced and oxidized forms (Wang et al., 2012). In oxidized form
of PDI the active site of a and a’ are 40.3 Å apart and the thiore-
doxin domains abb’a’ were all in the same plane (Wang et al.,
2013). In the reduced state of PDI the active sites are 27.6 Å,
however only abb’ are in the same plane where a’ is twisted
45◦ (Figure 2) (Wang et al., 2013), illustrating that the oxidized
state has a more open conformation allowing for the entry of
chaperone substrates (i.e., unfolded peptides) and the reduced
state has a closed conformation inhibiting their entry. This further
illustrates long range conformational changes induced by redox
status of the active sites and further suggests redox regulation of
chaperone activity.
Another interesting observation came from the work of Fu
et al., where the hormone 17β-estradiol was able to bind to the
hydrophobic cavity formed between the bb’ domains (Fu et al.,
2011). It should be noted that this site is different from the puta-
tive chaperone binding site in the b’ domain. The key amino acid
residue in the interaction of PDI with 17β-estradiol was shown to
H256 where it is believed that nitrogen of the histidine forms a
hydrogen bond with the 3-hydroxyl group (Fu et al., 2011). The
authors, based on this data, postulate yet another physiological
role for PDI: a reservoir for hormones (Fu et al., 2011).
PDI REDOX ACTIVITY AND ENDOPLASMIC RETICULUM
OXIDOREDUCTIN-1
When PDI catalyzes the oxidation of thiols and the reduction
and isomerization of disulfides, the catalytic vicinal active site
thiols (-CXXC-) undergo sequential oxidation and reduction
reactions. It is suggested that an oxidized a-domain catalyzes the
oxidation of the reduced substrates and in the process becomes
reduced. The N-terminus cysteine (C53) on the catalytic motif
reacts with the substrate to form the mixed heterodimer while
the C-terminus cysteine (C56) releases the substrate (Walker and
Gilbert, 1997). The a-domain is then subsequently oxidized by
the a’-domain back to a disulfide through intramolecular reac-
tions (Araki et al., 2013). The re-oxidation of the a’-domain is
catalyzed by the protein endoplasmic reticulum oxidoreductin-
1 (Ero1) in the process reducing O2 to produce H2O2 (Araki
and Nagata, 2011). It should be noted that this enzyme has two
isoforms α and β (Wang et al., 2011). The binding affinity and
catalytic activity of Ero1α with PDI was observed to be better
at pH 7, and less so at 7.5 and 8 (Araki and Nagata, 2011). The
interaction of Ero1α with PDI occurs through the interaction of
the βhairpin in Ero1α with the b’-domain of reduced PDI only
(Masui et al., 2011). The non-covalent interaction was found to
be between the aromatic residues, the W272 of Ero1α and F240,
F249, and F304 of PDI (Masui et al., 2011). This interaction allows
for Ero1α to be positioned in a manner that allows the oxidation
of the a’-domain of PDI but not the a-domain (Araki and Nagata,
2011; Masui et al., 2011). NMR studies on Ero1α indicate that it
is inactivated when disulfides are formed between C94–C104 and
C99–C131 (Araki andNagata, 2011). This conclusion was reached
since C99 is the residue responsible for oxidizing the a’-domain of
PDI. Therefore, it is thought the formation of disulfide between
C94 and C104 results in the C99 close C131. The subsequent for-
mation of the disulfide C99–C131 thus inactivates Ero1α (Araki
et al., 2013). The other isoform, Ero1β was observed to also pref-
erentially oxidize the a’ domain of PDI (Nguyen et al., 2011;Wang
et al., 2011).
A further consequence of Ero1 activity is the oxidation of the
a-domain of PDI. This is modulated through three other ER res-
ident proteins: peroxiredoxin 4 (Prx IV), glutathione peroxidase
7 (GPx7), and glutathione peroxidase 8 (GPx8) (Kakihana et al.,
2013; Wang et al., 2014). GPx7 and GPx8 catalyzes the reduction
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FIGURE 2 | Crystal Structure of Reduced and Oxidized PDI. (A)
Reduced crystal structure of human PDI (PDB ID: 4EKZ). (B) Oxidized
crystal structure of human PDI (PDB ID: 4EL1). (C) Schematic of PDI
domains present in the crystal structure, as well as the two active site
CXXC motifs (Crystal structures created using Swiss PDBViewer) (Wang
et al., 2013).
of Ero1-produced H2O2 to water. In the process, the C57 and
C86 of GPx7 are converted to sulfenic acid and disulfide respec-
tively. The PDI a-domain then reduces these thiols, becoming
oxidized in the process (Wang et al., 2014). When GPx7 or GPx8
was replaced with Prx IV this caused a slower oxidative folding of
protein in comparison with either GPx7 or GPx8 (Nguyen et al.,
2011). It is still controversial whether proteins such as, Ero1α,
are the primary cause of the oxidation of PDI, since oxidized
glutathione (GSSG) can also oxidize PDI active sites (Lappi and
Ruddock, 2011). The second-order rate constant for the forma-
tion of mixed disulfide from reduced PDI and GSSGwas observed
to be 191 ± 3 M−1s−1 (Lappi and Ruddock, 2011). In vivo stud-
ies of the rate of oxidation of the a domain of PDI by GSSG
were found to be ∼0.3 s−1, indicating that this rate is too fast
to be overlooked (Lappi and Ruddock, 2011). The oxidation of
PDI by excess H2O2 is also observed and has a pseudo-first-order
reaction with a rate constant of 9.2 M−1s−1 (Karala et al., 2009).
However this study was conducted solely on the a domain on PDI,
further studies of glutathione and glutathione disulfide on the
oxidation of PDI are required to determine howmuch affect these
molecules have on PDI. It should also be noted that more research
must be conducted on how much affect PDI has on controlling
the equilibrium of glutathione and glutathione disulfide.
PDI INHIBITORS
With the importance of PDI in many different cellular functions,
there has been an increased interest in the modulation of its activ-
ity with small molecule inhibitors. A commonly used inhibitor
of PDI is bacitracin, which is a mixture of cyclic polypeptides.
Recently, the analogs of bacitracin were individually tested to
observe their inhibitory effect on the reductive activity of PDI.
The analogs H and F were 25-fold more effective than the A and
B analogs (Dickerhof et al., 2011). These analogs bind to the b’
domain and interestingly do not seem to inhibit the oxidative and
isomerase activity of PDI (Roth, 1981; Dickerhof et al., 2011).
Another inhibitor of PDI reductase activity is quercetin-3-
rutinoside. This compound inhibits PDI mediated platelet aggre-
gation as a result has been suggested as antithrombic agent (Jasuja
et al., 2012). Phenyl vinyl sulfonate containing molecules were
also showed to inhibit PDI (Ge et al., 2013). The inhibitor des-
ignated P1 was observed to inhibit PDI in mammalian cells with
an IC50 of 1.7 ± 0.4μm (Ge et al., 2013).
Propynoic acid carbamoyl methyl amides (PACMA) also
inhibit PDI (Xu et al., 2012). Of these, the one designated
PACMA31 was observed to be an irreversible inhibitor, by form-
ing a covalent (carbon-sulfur) bond to the active site cysteine (Xu
et al., 2012). Intriguingly, this inhibitor was observed to target
ovarian tumors, inhibiting their growth but not causing harm to
normal cells (Xu et al., 2012).
PDI AND NADPH OXIDASE
NADPH oxidase complex (Nox) is the major contributor of reac-
tive oxygen species (ROS) in cells which can act as molecular
signal and when produced in excess can cause oxidative stress
(Janiszewski et al., 2005; Clempus and Griendling, 2006; Bedard
and Krause, 2007; Marchetti et al., 2007). The NADPH oxidase
complex is comprised of many subunits, that are expressed differ-
ently depending on the cell type (Janiszewski et al., 2005; Clempus
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and Griendling, 2006; Bedard and Krause, 2007; Marchetti et al.,
2007). Laurindo’s group were the first to report a role for PDI in
the regulation of Nox. PDI is shown to interact with Nox within
the ER as well as outside the ER in the cytosol (Laurindo et al.,
2008, 2014; Santos et al., 2009b).
More recently, Fernandes et al. showed that in vascular smooth
muscle cells, the overexpression of PDI increased Nox1 mRNA
which encodes for NOX1 in NADPH oxidase complex (Fernandes
et al., 2009). The PDI overexpression also produced an increase
in the activity of NADPH oxidase, leading to an increase in
the steady-state levels of ROS (Fernandes et al., 2009). Silencing
of PDI triggered a decrease in mRNA and protein of Nox1
(Fernandes et al., 2009). Overexpression of a mutant PDI where
the catalytic cysteines were mutated resulted in the increase in
Nox1 mRNA and protein indicating that PDI redox activity is not
required and it is most likely the chaperone activity of PDI that is
modulating this effect (Fernandes et al., 2009).
In other studies, PDI silencing has shown to greatly decrease
platelet derived growth factor (PDGF)-induced VSMC migra-
tion (Pescatore et al., 2012). In the same study, it was observed
that PDI co-immunoprecipitated with Rac1, RhoA, and RhoGDI
(Pescatore et al., 2012). In macrophages, PDI plays a similar role
where interaction with NADPH oxidase causes an increase in ROS
(Santos et al., 2009a). Laurindo’s group has shown that PDI co-
immuneprecipitated and co-localized with p22phox subunit of
NADPH oxidase in J774 cells (Santos et al., 2009a). They also
used a leukocyte cell free system to observe the interaction of PDI
with NADPH oxidase. They found that oxidized PDI stimulates
ROS production however reduced PDI inhibited the produc-
tion of ROS (De et al., 2011). This group further suggests that
PDI possibly interacts with p47phox subunit of NADPH oxidase
through hydrophobic effects and not through cysteines (Santos
et al., 2009a). From all this data it can be suggested that PDI plays
an important role in the regulation of ROS.
PDI AND INFECTION
The internalization of some pathogens has been shown to be
modulated by PDI. Ryser and coworkers were the first to test
the potential role of PDI in the internalization of pathogens
(Ryser et al., 1994). In mouse macrophage J774 cells, Laurindo’s
group observed that increased levels of PDI would increase the
phagocytosis of L. chagasi promastigote but not the amastigote
(Santos et al., 2009a). Phagocytosis was decreased by inhibi-
tion of expression levels of PDI as well as through the addition
of thiol inhibitors such as p-phenylarsine oxide (Santos et al.,
2009a). Santos and coworkers hypothesized that PDI plays a role
in the reduction of the disulfide bonds present on the para-
site, which may help with internalization of the parasite (Santos
et al., 2009a). They also suggest that PDI’s role in the increase
of ROS through the NADPH oxidase interaction resulting in an
“intraphagosomal-oxidizing milieu” and thus favoring infection
of promastigotes (Santos et al., 2009a).
Reiser and coworkers have examined the role of PDI in HIV
infections. Both PDI and thioredoxin 1 (Trx1) have been shown
to reduce disulfides on the viral glycoprotein gp120 causing the
internalization of HIV-1 (Reiser et al., 2012). Through semi-
quantitative ELISA analysis it was observed that Trx1 was more
efficient at reducing disulfides on gp120, however the authors
hypothesize that the two proteins may be acting at different stages
of internalization (Reiser et al., 2012). Interestingly, galectin-9 was
observed to bind to PDI on Th2 cells this helped with the reten-
tion of PDI to the cell surface as well as increased the entry of HIV
into these cells (Bi et al., 2011). It is suggested that inhibitors of
gp120 that prevent the reduction of the disulfides maybe a bet-
ter drug target than reductases since reductases are widely used in
cells (Reiser et al., 2012).
In endothelial cells surface PDI possibly reduces β1 and β3
integrins allowing for the entry of dengue virus (Wan et al., 2012).
Also in MA104 cells thiol blockers and PDI inhibitors decreased
the entry of rotavirus, indicating the involvement of thiols for
infectivity (Calderon et al., 2012).
Recently, PDI was observed to regulate the cytoskeleton reor-
ganization by its interaction with β-actin (Sobierajska et al.,
2014). PDI was observed to bind to Cys374 of β-actin through
a disulfide bond (Sobierajska et al., 2014). In MEG-01 cells the
down regulation of PDI resulted in the prevention of adhesion to
fibronectin (Sobierajska et al., 2014).
During the bacterial infection of the cholera toxin it is
observed that PDI does not unfold the CT protein into its sub-
unit CTA1 for further infection (Taylor et al., 2011). Nevertheless,
PDI does disassemble the holotoxin allowing for the dissociation
of CTA1 from CTA2 and CTB5 and its spontaneous unfolding,
allowing CTA1 to exit the ER (Taylor et al., 2011). Interestingly,
Taylor and coworkers recently discovered that PDI when inter-
acting with the holotoxin, will itself unfold, causing a wedge to
form between the holotoxin and causing the dissociation of CTA1
(Taylor et al., 2014). PDI locked in the folded state would not dis-
sociate the holotoxin (Taylor et al., 2014). This appears not to
required the oxireductase activity of PDI since redox inhibitors
had no effect on toxin activation. On the other hand, chaperone
inhibitors prevent the release of CTA1 thus indicating that PDI
unfolding in the presence of holotoxin requires PDI chaperone
activity (Taylor et al., 2014).
PDI AND COAGULATION
The activation of platelets is a complex series of proteolytic,
protein-protein, and protein-ligand interactions that is not yet
fully understood. A quick summary of this process is, that dam-
aged endothelial cells will cause the exposure of collagen allowing
for the glycoprotein, von Willebrand factor to attract platelets
(Lopez et al., 1992; Modderman et al., 1992; Ruggeri, 2007; Herr
and Farndale, 2009). The platelets form a monolayer, which in
turns produces thrombin for additional platelet aggregation and
causes a series of cascades (Monroe et al., 2002; Clemetson, 2012).
The platelets also start to secrete other activators these will bind
to receptor on the platelets and increase the intracellular calcium
levels (Purvis et al., 2008). This causes receptors on platelets to
bind fibrinogen resulting in the increase adhesion of the platelets
and the formation of thrombi(Ma et al., 2007; Furie and Furie,
2008).Many of the integrin receptors associated with platelet acti-
vation contain a cysteine rich subunit, possibly allowing for PDI
to regulate the redox state of the thiols.
Platelets deficient of PDI display irregular and improper aggre-
gation, when wild-type PDI is added the aggregation of platelets
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returns to normal (Kim et al., 2013). PDI on the surface of
platelets plays a crucial role in the formation of thrombus in
collagen-coated platelets (Kim et al., 2013). In monocytic cells,
cell surface PDI is required for antithymocyte globulin decryption
of tissue factor (Langer et al., 2013).
Recent studies have shown that free thiols and isomerization
are associated with the process of coagulation (Jurk et al., 2011).
In vitro studies by Jurk and coworkers have shown that PDI plays
a role in the feedback activation of thrombin in platelets that have
already been stimulated by thrombin (Jurk et al., 2011). In the
same paper, they showed that PDI may play a role in the interac-
tion of coagulation factors with platelets (Jurk et al., 2011). With
the use of CHO cells expressing different integrin factors, αVβ3
and αIIbβ3,PDI was observed to bind to these integrin molecules
(Cho et al., 2012). This binding of PDI with the integrin was
determined to be through the β3 subunit and not the α subunit
(Cho et al., 2012). The binding of PDI to integrins was not inhib-
ited by the presence of PDI redox inhibitors, the authors however
do not hypothesize how this interaction is occurring (Cho et al.,
2012). In a mice model, where there is a deficiency in β3 integrins,
it is observed that fibrin generation was diminished from the lack
of accumulation of PDI at the platelet surface (Cho et al., 2012).
In neutrophil cells, PDI may mediate the adhesive activity during
vasculature inflammation through its interaction with αMβ2 inte-
grin (Hahm et al., 2013). With the use of flow cytometry, it was
observed that exogenous PDI interacted with neutrophil cell sur-
face by electrostatic interactions (Hahm et al., 2013). The authors
propose that PDI catalyzes thiol exchange through electrostatic
interactions of αMβ2 integrin thus regulating the clustering of the
integrin within lipid rafts (Hahm et al., 2013). It should also be
noted that vitamin K epoxide reductase, an important enzyme in
blood coagulation, requires the help of a thioredoxin-like protein
to regenerate vitamin K hydroquinone from the epoxide form.
It is speculated that the PDI is the thioredoxin-like protein that
provides the reductive equivalent to perform the regeneration
(Schulman et al., 2010).
In endothelial cells, when PDI was silenced or inhibited on the
cell surface, the coagulation was increased (Popescu et al., 2010).
In agreement with this finding, it was observed that addition of
exogenous PDI resulted in the decrease in coagulation activity
(Popescu et al., 2010). The authors suggest that coagulation of
endothelial cells is negatively regulated by PDI, specifically its oxi-
doreductase activity (Popescu et al., 2010). In the same study, it
was also observed that PDI may play a role in the regulation of
phosphatidylserine exposure through the activity of flippase and
floppase (Popescu et al., 2010).
For more information of previous knowledge on the effects of
redox on coagulation can be found in reviews by Cho (2013),
Flaumenhaft (2013), Langer and Ruf (2014), and Murphy et al.
(2014).
PDI AND SUPEROXIDE DISMUTASE 1
Protein aggregation has been shown to occur in a variety of neu-
rodegenerative diseases and disorders, such as cerebral ischemia
and amyotrophic lateral sclerosis. Cai and coworkers were one
of the first to show that PDI alleviates the aggregation of pro-
teins (Cai et al., 1994). Cerebral ischemia is caused by decrease
blood flow to the brain resulting in the loss of oxygen to neu-
rons and astrocytes, which has shown to cause an increase in
nitric oxide (NO) production specifically by inducible nitric
oxide synthase (iNOS) (Cherian et al., 2000; Greve and Zink,
2009). Elevated NO production can lead to the inactivation
of proteins by S-nitrosylation. In astrocytes, recent studies by
Chen have shown the presence of S-nitrosylated PDI (SNO-PDI),
which has previously been shown to inhibit the activity of PDI
(Ramachandran et al., 2001; Chen et al., 2012). When the cells
were oxygen deprived, this caused the formation of ubiquiti-
nated protein aggregates, of proteins like superoxide dismutase 1
(SOD1), which is crucial to cell survival (Chen et al., 2012).
When NO production in these cells was attenuated, the forma-
tion of both SNO-PDI and protein aggregates decreased (Chen
et al., 2012). Interestingly, in SH-SY5Y cells the overexpression
of mutant SOD1 caused an increase expression of iNOS, where
wild type SOD1 did not cause any increase (Chen et al., 2013).
SOD1 is a protein that alleviates oxidative stress by converting
free radicals to H2O2 (Chen et al., 2012). The mutant SOD1
expressing cells were observed to contain SNO-PDI and protein
aggregation while the wild type SOD1 did not show any increase
in either, this was also observed in vivo, in transgenic mice (Chen
et al., 2013). Furthermore, the expression of PDI increased when
protein aggregates accumulated in cells, and the cells became
apoptotic (Hoffstrom et al., 2010; Chen et al., 2013).
The aggregation of mutant SOD1 has shown to cause an
increase in neuronal cell death in amyotrophic lateral sclerosis,
it has been hypothesized that denitrosylation of PDI can be con-
sidered as a therapeutic intervention for this disease (Jeon et al.,
2014). In both HEK293A cells and NSC-34 motor neuron cells,
the overexpression of PDI lead to a decrease in the aggregation
of mutant SOD1 (Jeon et al., 2014). The interaction of PDI with
SOD1 appears to be through the chaperone activity of PDI rather
than the isomerase activity since aggregation was also reduced
with mutant PDI lacking active site thiols (Jeon et al., 2014).
Intriguingly, the overexpression of PDI caused by mutant SOD1
has shown to cause the activation of NADPH oxidase causing
an increase in ROS (Jaronen et al., 2013). In murine microglial
BV-2 cells Nox activation was PDI-dependent suggesting that
PDI inhibitors may help reduce oxidative stress in cells (Jaronen
et al., 2013). However, further studies must be conducted to deter-
mine PDI’s role in the interplay of protein aggregation and the
production of ROS.
ROLE OF PDI IN NITRIC OXIDE SIGNALING
Our group was the first to show that cell surface PDI medi-
ated the entry of S-nitrosothiols (SNO) into cells (Ramachandran
et al., 2001). Cell surface PDI was observed to release NO from
S-nitrosylated glutathione (GSNO), one of the main nitric oxide
carriers in tissues (Root et al., 2004). PDI would denitrosylate
GSNO when NO levels were low, however during high levels of
NO, PDI would act as a carrier either through the formation of
SNO-PDI (Sliskovic et al., 2005).
Recently our group, showed that PDI plays a role in the
transport of nitric oxide from red blood cells to endothelium
cells (Kallakunta et al., 2013). This process was observed to
be oxygen-dependent where nitric oxide bound hemoglobin
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FIGURE 3 | The formation of NO+/NO from nitrite during hypoxic
conditions by Hb and the transfer of nitric oxide to endothelium by PDI.
(1) Nitrite reacts with Hb under hypoxic conditions to form Fe(II)-NO. (2) PDI
from blood equilibrates across the plasma membrane of red blood cells to
form a complex with Hb. (3) When red blood cells enter the lungs the O2
displaces the NO from the iron on the heme group to PDI thiols or to Hb (Cys
β93), resulting in the formation of SNO-PDI. (4) PDI attaches to the
extracellular surface of red blood cells under normoxic conditions. (5) When
the red blood cells enter tissue that is under hypoxic conditions, SNO-PDI is
released. (6) SNO-PDI interacts with the endothelium cells, releasing
NO+/NO triggering hypoxic vasodilation. Image taken from Kallakunta et al.
(2013).
(NO-Hb) required hypoxic conditions. Oxygen is then required
for the formation of SNO-Hb, which then transfers the nitric
oxide to PDI to form SNO-PDI (Kallakunta et al., 2013).
When hemoglobin is half oxygen saturated it was observed that
nitric oxide would dissociate from extracellular PDI and be
transferred to endothelium cells (Figure 3) (Kallakunta et al.,
2013).
CONCLUSION
During the early years of research on PDI it was well thought
of that PDI was required for the maintenance of healthy cells
and tissues, in view of the catalytic roles of PDI in reducing
and isomerizing disulfides into native confirmations of pro-
teins and to alleviate protein aggregates through its chaper-
one activity. However recent studies indicate that this may not
be the case. PDI through its thiol redox activity, is observed
to play a role for the internalization of some pathogens,
as well as it is shown to promote increased ROS in cells.
Furthermore, in neuronal cells post transnationally modified
SNO-PDI etc. has been shown to promote protein aggrega-
tion commonly associated with the pathophysiology of neu-
rodegenerative diseases. These observations show that PDI is a
complex protein that can play a role in both physiology and
pathophysiology. Therefore, further studies are warranted in
order to solve the complex relationships of PDI in health and
disease.
ACKNOWLEDGMENT
This work was supported by a NSERC Discovery Grant to Bulent
Mutus and was supported by the University of Windsor tuition
scholarship.
REFERENCES
Alanen, H. I., Salo, K. E., Pekkala, M., Siekkinen, H. M., Pirneskoski, A.,
and Ruddock, L. W. (2003). Defining the domain boundaries of the
human protein disulfide isomerases. Antioxid. Redox Signal. 5, 367–374. doi:
10.1089/152308603768295096
Andreu, C. I., Woehlbier, U., Torres, M., and Hetz, C. (2012). Protein disul-
fide isomerases in neurodegeneration: from disease mechanisms to biomed-
ical applications. FEBS Lett. 586, 2826–2834. doi: 10.1016/j.febslet.2012.
07.023
Araki, K., Iemura, S., Kamiya, Y., Ron, D., Kato, K., Natsume, T., et al. (2013).
Ero1-alpha and PDIs constitute a hierarchical electron transfer network
of endoplasmic reticulum oxidoreductases. J. Cell Biol. 202, 861–874. doi:
10.1083/jcb.201303027
Araki, K., and Nagata, K. (2011). Functional in vitro analysis of the ERO1 protein
and protein-disulfide isomerase pathway. J. Biol. Chem. 286, 32705–32712. doi:
10.1074/jbc.M111.227181
Bastos-Aristizabal, S., Kozlov, G., and Gehring, K. (2014). Structural insight into
the dimerization of human protein disulfide isomerase. Protein Sci. 23, 618–626.
doi: 10.1002/pro.2444
Bedard, K., and Krause, K.-H. (2007). The NOX family of ROS-generating NADPH
oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245–313. doi:
10.1152/physrev.00044.2005
Benham, A. M. (2012). The protein disulfide isomerase family: key players in
health and disease. Antioxid. Redox Signal. 16, 781–789. doi: 10.1089/ars.
2011.4439
Frontiers in Chemistry | Cellular Biochemistry August 2014 | Volume 2 | Article 70 | 6
Khan and Mutus Protein disulfide isomerase a multifunctional protein
Ben Khalaf, N., De Muylder, G., Louzir, H., Mckerrow, J., and Chenik, M.
(2012). Leishmania major protein disulfide isomerase as a drug target: enzy-
matic and functional characterization. Parasitol. Res. 110, 1911–1917. doi:
10.1007/s00436-011-2717-5
Bi, S., Hong, P. W., Lee, B., and Baum, L. G. (2011). Galectin-9 binding to cell
surface protein disulfide isomerase regulates the redox environment to enhance
T-cell migration and HIV entry. Proc. Natl. Acad. Sci. U.S.A. 108, 10650–10655.
doi: 10.1073/pnas.1017954108
Bulleid, N. J., and Ellgaard, L. (2011). Multiple ways to make disulfides. Trends
Biochem. Sci. 36, 485–492. doi: 10.1016/j.tibs.2011.05.004
Cai, H., Wang, C. C., and Tsou, C. L. (1994). Chaperone-like activity of protein
disulfide isomerase in the refolding of a protein with no disulfide bonds. J. Biol.
Chem. 269, 24550–24552.
Calderon, M. N., Guerrero, C. A., Acosta, O., Lopez, S., and Arias, C. F.
(2012). Inhibiting rotavirus infection by membrane-impermeant thiol/disulfide
exchange blockers and antibodies against protein disulfide isomerase.
Intervirology 55, 451–464. doi: 10.1159/000335262
Chen, X., Guan, T., Li, C., Shang, H., Cui, L., Li, X. M., et al. (2012). SOD1 aggrega-
tion in astrocytes following ischemia/reperfusion injury: a role of NO-mediated
S-nitrosylation of protein disulfide isomerase (PDI). J. Neuroinflammation 9,
237. doi: 10.1186/1742-2094-9-237
Chen, X., Zhang, X., Li, C., Guan, T., Shang, H., Cui, L., et al. (2013). S-nitrosylated
protein disulfide isomerase contributes to mutant SOD1 aggregates in amy-
otrophic lateral sclerosis. J. Neurochem. 124, 45–58. doi: 10.1111/jnc.12046
Cherian, L., Goodman, J. C., and Robertson, C. S. (2000). Brain nitric oxide
changes after controlled cortical impact injury in rats. J. Neurophysiol. 83,
2171–2178. doi: 10.1097/00003246-199901001-00091
Cho, J. (2013). Protein disulfide isomerase in thrombosis and vascular inflamma-
tion. J. Thromb. Haemost. 11, 2084–2091. doi: 10.1111/jth.12413
Cho, J., Kennedy, D. R., Lin, L., Huang, M., Merrill-Skoloff, G., Furie, B. C.,
et al. (2012). Protein disulfide isomerase capture during thrombus formation
in vivo depends on the presence of beta3 integrins. Blood 120, 647–655. doi:
10.1182/blood-2011-08-372532
Clemetson, K. J. (2012). Platelets and primary haemostasis. Thromb. Res. 129,
220–224. doi: 10.1016/j.thromres.2011.11.036
Clempus, R. E., and Griendling, K. K. (2006). Reactive oxygen species sig-
naling in vascular smooth muscle cells. Cardiovasc. Res. 71, 216–225. doi:
10.1016/j.cardiores.2006.02.033
De, A. P.A. M., Verissimo-Filho, S., Guimaraes, L. L., Silva, A. C., Takiuti, J. T., and
Lopes, L. R. (2011). Protein disulfide isomerase redox-dependent association
with p47(phox): evidence for an organizer role in leukocyte NADPH oxidase
activation. J. Leukoc. Biol. 90, 799–810. doi: 10.1189/jlb.0610324
Denisov, A. Y., Maattanen, P., Dabrowski, C., Kozlov, G., Thomas, D. Y.,
and Gehring, K. (2009). Solution structure of the bb’ domains of human
protein disulfide isomerase. FEBS J. 276, 1440–1449. doi: 10.1111/j.1742-
4658.2009.06884.x
Dickerhof, N., Kleffmann, T., Jack, R., and Mccormick, S. (2011). Bacitracin
inhibits the reductive activity of protein disulfide isomerase by disulfide bond
formation with free cysteines in the substrate-binding domain. FEBS J. 278,
2034–2043. doi: 10.1111/j.1742-4658.2011.08119.x
Edman, J. C., Ellis, L., Blacher, R. W., Roth, R. A., and Rutter, W. J. (1985).
Sequence of protein disulphide isomerase and implications of its relationship
to thioredoxin. Nature 317, 267–270.
Fernandes, D. C., Manoel, A. H., Wosniak, J. Jr., and Laurindo, F. R. (2009). Protein
disulfide isomerase overexpression in vascular smooth muscle cells induces
spontaneous preemptive NADPH oxidase activation and Nox1 mRNA expres-
sion: effects of nitrosothiol exposure. Arch. Biochem. Biophys. 484, 197–204. doi:
10.1016/j.abb.2009.01.022
Flaumenhaft, R. (2013). Protein disulfide isomerase as an antithrombotic target.
Trends Cardiovasc. Med. 23, 264–268. doi: 10.1016/j.tcm.2013.03.001
Freedman, R. B., Gane, P. J., Hawkins, H. C., Hlodan, R., Mclaughlin, S. H.,
and Parry, J. W. (1998). Experimental and theoretical analyses of the domain
architecture of mammalian protein disulphide-isomerase. Biol. Chem. 379,
321–328.
Fu, X.M.,Wang, P., and Zhu, B. T. (2011). Characterization of the estradiol-binding
site structure of human protein disulfide isomerase (PDI). PLoS ONE 6:e27185.
doi: 10.1371/journal.pone.0027185
Furie, B., and Furie, B. C. (2008). Mechanisms of thrombus formation. N. Engl. J.
Med. 359, 938–949. doi: 10.1056/NEJMra0801082
Ge, J., Zhang, C. J., Li, L., Chong, L. M., Wu, X., Hao, P., et al. (2013). Small
molecule probe suitable for in situ profiling and inhibition of protein disulfide
isomerase. ACS Chem. Biol. 8, 2577–2585. doi: 10.1021/cb4002602
Goldberger, R. F., Epstein, C. J., and Anfinsen, C. B. (1963). Acceleration of reacti-
vation of reduced bovine pancreatic ribonuclease by a microsomal system from
rat liver. J. Biol. Chem. 238, 628–635.
Greve, M. W., and Zink, B. J. (2009). Pathophysiology of traumatic brain injury.
Mt. Sinai J. Med. 76, 97–104. doi: 10.1002/msj.20104
Hahm, E., Li, J., Kim, K., Huh, S., Rogelj, S., and Cho, J. (2013). Extracellular
protein disulfide isomerase regulates ligand-binding activity of alphaMbeta2
integrin and neutrophil recruitment during vascular inflammation. Blood 121,
3789–3800, S3781–S3715. doi: 10.1182/blood-2012-11-467985
Hashimoto, S., and Imaoka, S. (2013). Protein-disulfide isomerase regulates
the thyroid hormone receptor-mediated gene expression via redox factor-
1 through thiol reduction-oxidation. J. Biol. Chem. 288, 1706–1716. doi:
10.1074/jbc.M112.365239
Herr, A. B., and Farndale, R. W. (2009). Structural insights into the interac-
tions between platelet receptors and fibrillar collagen. J. Biol. Chem. 284,
19781–19785. doi: 10.1074/jbc.R109.013219
Hoffstrom, B. G., Kaplan, A., Letso, R., Schmid, R. S., Turmel, G. J., Lo, D. C., et al.
(2010). Inhibitors of protein disulfide isomerase suppress apoptosis induced by
misfolded proteins. Nat. Chem. Biol. 6, 900–906. doi: 10.1038/nchembio.467
Holmgren, A. (1968). Thioredoxin. 6. The amino acid sequence of the protein from
Escherichia coli B. Eur. J. Biochem. 6, 475–484.
Irvine, A. G., Wallis, A. K., Sanghera, N., Rowe, M. L., Ruddock, L. W., Howard, M.
J., et al. (2014). Protein disulfide-isomerase interacts with a substrate protein
at all stages along its folding pathway. PLoS ONE 9:e82511. doi: 10.1371/jour-
nal.pone.0082511
Janiszewski, M., Lopes, L. R., Carmo, A. O., Pedro, M. A., Brandes, R. P., Santos, C.
X., et al. (2005). Regulation of NAD(P)H oxidase by associated protein disulfide
isomerase in vascular smoothmuscle cells. J. Biol. Chem. 280, 40813–40819. doi:
10.1074/jbc.M509255200
Jaronen, M., Vehvilainen, P., Malm, T., Keksa-Goldsteine, V., Pollari, E., Valonen,
P., et al. (2013). Protein disulfide isomerase in ALS mouse glia links protein
misfolding with NADPH oxidase-catalyzed superoxide production. Hum. Mol.
Genet. 22, 646–655. doi: 10.1093/hmg/dds472
Jasuja, R., Passam, F. H., Kennedy, D. R., Kim, S. H., Van Hessem, L., Lin,
L., et al. (2012). Protein disulfide isomerase inhibitors constitute a new
class of antithrombotic agents. J. Clin. Invest. 122, 2104–2113. doi: 10.1172/
JCI61228
Jeon, G. S., Nakamura, T., Lee, J.-S., Choi, W.-J., Ahn, S.-W., Lee, K.-W., et al.
(2014). Potential effect of S-nitrosylated protein disulfide isomerase on mutant
SOD1 aggregation and neuronal cell death in amyotrophic lateral sclerosis.Mol.
Neurobiol. 49, 796–807. doi: 10.1007/s12035-013-8562-z
Jurk, K., Lahav, J., VAN Aken, H., Brodde, M. F., Nofer, J. R., and Kehrel, B.
E. (2011). Extracellular protein disulfide isomerase regulates feedback acti-
vation of platelet thrombin generation via modulation of coagulation factor
binding. J. Thromb. Haemost. 9, 2278–2290. doi: 10.1111/j.1538-7836.2011.
04509.x
Kakihana, T., Araki, K., Vavassori, S., Iemura, S., Cortini, M., Fagioli, C.,
et al. (2013). Dynamic regulation of Ero1alpha and peroxiredoxin 4 local-
ization in the secretory pathway. J. Biol. Chem. 288, 29586–29594. doi:
10.1074/jbc.M113.467845
Kallakunta, V. M., Slama-Schwok, A., and Mutus, B. (2013). Protein disulfide iso-
merase may facilitate the efflux of nitrite derived S-nitrosothiols from red blood
cells. Redox Biol. 1, 373–380. doi: 10.1016/j.redox.2013.07.002
Karala, A. R., Lappi, A. K., Saaranen, M. J., and Ruddock, L. W. (2009). Efficient
peroxide-mediated oxidative refolding of a protein at physiological pH and
implications for oxidative folding in the endoplasmic reticulum.Antioxid. Redox
Signal. 11, 963–970. doi: 10.1089/ARS.2008.2326
Kemmink, J., Darby, N. J., Dijkstra, K., Nilges, M., and Creighton, T. E. (1997). The
folding catalyst protein disulfide isomerase is constructed of active and inactive
thioredoxin modules. Curr. Biol. 7, 239–245.
Kim, K., Hahm, E., Li, J., Holbrook, L. M., Sasikumar, P., Stanley, R. G., et al.
(2013). Platelet protein disulfide isomerase is required for thrombus formation
but not for hemostasis inmice. Blood 122, 1052–1061. doi: 10.1182/blood-2013-
03-492504
Koch, G. L. (1987). Reticuloplasmins: a novel group of proteins in the endoplasmic
reticulum. J. Cell Sci. 87(Pt 4), 491–492.
www.frontiersin.org August 2014 | Volume 2 | Article 70 | 7
Khan and Mutus Protein disulfide isomerase a multifunctional protein
Kozlov, G., Maattanen, P., Thomas, D. Y., and Gehring, K. (2010). A struc-
tural overview of the PDI family of proteins. FEBS J. 277, 3924–3936. doi:
10.1111/j.1742-4658.2010.07793.x
Langer, F., and Ruf, W. (2014). Synergies of phosphatidylserine and protein disul-
fide isomerase in tissue factor activation. Thromb. Haemost. 111, 590–597. doi:
10.1160/TH13-09-0802
Langer, F., Spath, B., Fischer, C., Stolz, M., Ayuk, F. A., Kroger, N., et al. (2013).
Rapid activation of monocyte tissue factor by antithymocyte globulin is depen-
dent on complement and protein disulfide isomerase. Blood 121, 2324–2335.
doi: 10.1182/blood-2012-10-460493
Lappi, A. K., and Ruddock, L. W. (2011). Reexamination of the role of interplay
between glutathione and protein disulfide isomerase. J. Mol. Biol. 409, 238–249.
doi: 10.1016/j.jmb.2011.03.024
Laurindo, F. R., Araujo, T. L., and Abrahao, T. B. (2014). Nox NADPH oxidases
and the endoplasmic reticulum. Antioxid. Redox Signal. 20, 2755–2775. doi:
10.1089/ars.2013.5605
Laurindo, F. R., Fernandes, D. C., Amanso, A. M., Lopes, L. R., and Santos, C. X.
(2008). Novel role of protein disulfide isomerase in the regulation of NADPH
oxidase activity: pathophysiological implications in vascular diseases. Antioxid.
Redox Signal. 10, 1101–1113. doi: 10.1089/ars.2007.2011
Laurindo, F. R., Pescatore, L. A., and Fernandes Dde, C. (2012). Protein disulfide
isomerase in redox cell signaling and homeostasis. Free Radic. Biol. Med. 52,
1954–1969. doi: 10.1016/j.freeradbiomed.2012.02.037
Lopez, J. A., Leung, B., Reynolds, C. C., Li, C. Q., and Fox, J. E. (1992). Efficient
plasma membrane expression of a functional platelet glycoprotein Ib-IX com-
plex requires the presence of its three subunits. J. Biol. Chem. 267, 12851–12859.
Ma, Y. Q., Qin, J., and Plow, E. F. (2007). Platelet integrin alpha(IIb)beta(3):
activation mechanisms. J. Thromb. Haemost. 5, 1345–1352. doi: 10.1111/j.1538-
7836.2007.02537.x
Maattanen, P., Gehring, K., Bergeron, J. J., and Thomas, D. Y. (2010). Protein qual-
ity control in the ER: the recognition of misfolded proteins. Semin. Cell Dev.
Biol. 21, 500–511. doi: 10.1016/j.semcdb.2010.03.006
Marchetti, P., Bugliani, M., Lupi, R., Marselli, L., Masini, M., Boggi, U., et al. (2007).
The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients.
Diabetologia 50, 2486–2494. doi: 10.1007/s00125-007-0816-8
Marcus, N., Shaffer, D., Farrar, P., and Green, M. (1996). Tissue distribution of
three members of the murine protein disulfide isomerase (PDI) family. Biochim.
Biophys. Acta 1309, 253–260.
Mares, R. E., Melendez-Lopez, S. G., and Ramos, M. A. (2011). Acid-denatured
Green Fluorescent Protein (GFP) as model substrate to study the chaperone
activity of protein disulfide isomerase. Int. J. Mol. Sci. 12, 4625–4636. doi:
10.3390/ijms12074625
Masui, S., Vavassori, S., Fagioli, C., Sitia, R., and Inaba, K. (2011). Molecular bases
of cyclic and specific disulfide interchange between human ERO1alpha protein
and protein-disulfide isomerase (PDI). J. Biol. Chem. 286, 16261–16271. doi:
10.1074/jbc.M111.231357
McLaughlin, S. H., and Bulleid, N. J. (1998). Thiol-independent interaction of pro-
tein disulphide isomerase with type X collagen during intra-cellular folding and
assembly. Biochem. J. 331(Pt 3), 793–800.
Modderman, P. W., Admiraal, L. G., Sonnenberg, A., and Von Dem Borne, A. E.
(1992). Glycoproteins V and Ib-IX form a noncovalent complex in the platelet
membrane. J. Biol. Chem. 267, 364–369.
Monroe, D. M., Hoffman, M., and Roberts, H. R. (2002). Platelets and
thrombin generation. Arterioscler. Thromb. Vasc. Biol. 22, 1381–1389. doi:
10.1161/01.ATV.0000031340.68494.34
Murphy, D. D., Reddy, E. C., Moran, N., and O’neill, S. (2014). Regulation of
platelet activity in a changing redox environment. Antioxid. Redox Signal. 20,
2074–2089. doi: 10.1089/ars.2013.5698
Nguyen, V. D., Saaranen, M. J., Karala, A. R., Lappi, A. K., Wang, L., Raykhel, I.
B., et al. (2011). Two endoplasmic reticulum PDI peroxidases increase the effi-
ciency of the use of peroxide during disulfide bond formation. J. Mol. Biol. 406,
503–515. doi: 10.1016/j.jmb.2010.12.039
Noiva, R. (1999). Protein disulfide isomerase: the multifunctional redox chap-
erone of the endoplasmic reticulum. Semin. Cell Dev. Biol. 10, 481–493. doi:
10.1006/scdb.1999.0319
Pescatore, L. A., Bonatto, D., Forti, F. L., Sadok, A., Kovacic, H., and Laurindo, F.
R. (2012). Protein disulfide isomerase is required for platelet-derived growth
factor-induced vascular smooth muscle cell migration, Nox1 NADPH oxidase
expression, and RhoGTPase activation. J. Biol. Chem. 287, 29290–29300. doi:
10.1074/jbc.M112.394551
Popescu, N. I., Lupu, C., and Lupu, F. (2010). Extracellular protein disulfide
isomerase regulates coagulation on endothelial cells through modulation of
phosphatidylserine exposure. Blood 116, 993–1001. doi: 10.1182/blood-2009-
10-249607
Purvis, J. E., Chatterjee, M. S., Brass, L. F., and Diamond, S. L. (2008). A molecu-
lar signaling model of platelet phosphoinositide and calcium regulation during
homeostasis and P2Y1 activation. Blood 112, 4069–4079. doi: 10.1182/blood-
2008-05-157883
Ramachandran, N., Root, P., Jiang, X. M., Hogg, P. J., and Mutus, B. (2001).
Mechanism of transfer of NO from extracellular S-nitrosothiols into the cytosol
by cell-surface protein disulfide isomerase. Proc. Natl. Acad. Sci. U.S.A. 98,
9539–9544. doi: 10.1073/pnas.171180998
Reiser, K., Francois, K. O., Schols, D., Bergman, T., Jornvall, H., Balzarini, J., et al.
(2012). Thioredoxin-1 and protein disulfide isomerase catalyze the reduction
of similar disulfides in HIV gp120. Int. J. Biochem. Cell Biol. 44, 556–562. doi:
10.1016/j.biocel.2011.12.015
Root, P., Sliskovic, I., and Mutus, B. (2004). Platelet cell-surface protein
disulphide-isomerase mediated S-nitrosoglutathione consumption. Biochem. J.
382, 575–580. doi: 10.1042/BJ20040759
Roth, R. A. (1981). Bacitracin: an inhibitor of the insulin degrading activity
of glutathione-insulin transhydrogenase. Biochem. Biophys. Res. Commun. 98,
431–438.
Ruggeri, Z. M. (2007). The role of von Willebrand factor in thrombus formation.
Thromb. Res. 120(Suppl. 1), S5–S9. doi: 10.1016/j.thromres.2007.03.011
Ryser, H. J., Levy, E.M.,Mandel, R., andDisciullo, G. J. (1994). Inhibition of human
immunodeficiency virus infection by agents that interfere with thiol-disulfide
interchange upon virus-receptor interaction. Proc. Natl. Acad. Sci. U.S.A. 91,
4559–4563.
Santos, C. X., Stolf, B. S., Takemoto, P. V., Amanso, A. M., Lopes, L. R.,
Souza, E. B., et al. (2009a). Protein disulfide isomerase (PDI) associates with
NADPH oxidase and is required for phagocytosis of Leishmania chagasi pro-
mastigotes by macrophages. J. Leukoc. Biol. 86, 989–998. doi: 10.1189/jlb.
0608354
Santos, C. X., Tanaka, L. Y., Wosniak, J., and Laurindo, F. R. (2009b). Mechanisms
and implications of reactive oxygen species generation during the unfolded pro-
tein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial
electron transport, and NADPH oxidase. Antioxid. Redox Signal. 11, 2409–2427.
doi: 10.1089/ARS.2009.2625
Schulman, S., Wang, B., Li, W., and Rapoport, T. A. (2010). Vitamin K epox-
ide reductase prefers ER membrane-anchored thioredoxin-like redox part-
ners. Proc. Natl. Acad. Sci. U.S.A. 107, 15027–15032. doi: 10.1073/pnas.1009
972107
Shao, F., Bader, M. W., Jakob, U., and Bardwell, J. C. (2000). DsbG, a protein disul-
fide isomerase with chaperone activity. J. Biol. Chem. 275, 13349–13352. doi:
10.1074/jbc.275.18.13349
Sliskovic, I., Raturi, A., and Mutus, B. (2005). Characterization of the S-
denitrosation activity of protein disulfide isomerase. J. Biol. Chem. 280,
8733–8741. doi: 10.1074/jbc.M408080200
Sobierajska, K., Skurzynski, S., Stasiak, M., Kryczka, J., Cierniewski, C. S., and
Swiatkowska,M. (2014). Protein disulfide isomerase directly interacts with beta-
actin Cys374 and regulates cytoskeleton reorganization. J. Biol. Chem. 289,
5758–5773. doi: 10.1074/jbc.M113.479477
Taylor, M., Banerjee, T., Ray, S., Tatulian, S. A., and Teter, K. (2011). Protein-
disulfide isomerase displaces the cholera toxin A1 subunit from the holotoxin
without unfolding the A1 subunit. J. Biol. Chem. 286, 22090–22100. doi:
10.1074/jbc.M111.237966
Taylor, M., Burress, H., Banerjee, T., Ray, S., Curtis, D., Tatulian, S. A., et al.
(2014). Substrate-induced unfolding of protein disulfide isomerase displaces
the cholera toxin A1 subunit from its holotoxin. PLoS Pathog. 10:e1003925. doi:
10.1371/journal.ppat.1003925
Walker, K. W., and Gilbert, H. F. (1997). Scanning and escape during protein-
disulfide isomerase-assisted protein folding. J. Biol. Chem. 272, 8845–8848.
Wan, S. W., Lin, C. F., Lu, Y. T., Lei, H. Y., Anderson, R., and Lin, Y. S. (2012).
Endothelial cell surface expression of protein disulfide isomerase activates beta1
and beta3 integrins and facilitates dengue virus infection. J. Cell. Biochem. 113,
1681–1691. doi: 10.1002/jcb.24037
Frontiers in Chemistry | Cellular Biochemistry August 2014 | Volume 2 | Article 70 | 8
Khan and Mutus Protein disulfide isomerase a multifunctional protein
Wang, C., Li, W., Ren, J., Fang, J., Ke, H., Gong, W., et al. (2013). Structural insights
into the redox-regulated dynamic conformations of human protein disulfide
isomerase. Antioxid. Redox Signal. 19, 36–45. doi: 10.1089/ars.2012.4630
Wang, C., Yu, J., Huo, L., Wang, L., Feng, W., and Wang, C. C. (2012). Human
protein-disulfide isomerase is a redox-regulated chaperone activated by oxida-
tion of domain a’. J. Biol. Chem. 287, 1139–1149. doi: 10.1074/jbc.M111.303149
Wang, L., Zhang, L., Niu, Y., Sitia, R., and Wang, C. C. (2014). Glutathione
peroxidase 7 utilizes hydrogen peroxide generated by Ero1alpha to promote
oxidative protein folding. Antioxid. Redox Signal. 20, 545–556. doi: 10.1089/ars.
2013.5236
Wang, L., Zhu, L., and Wang, C. C. (2011). The endoplasmic reticulum sulfhydryl
oxidase Ero1beta drives efficient oxidative protein folding with loose regulation.
Biochem. J. 434, 113–121. doi: 10.1042/BJ20101357
Xu, S., Butkevich, A. N., Yamada, R., Zhou, Y., Debnath, B., Duncan, R., et al.
(2012). Discovery of an orally active small-molecule irreversible inhibitor of
protein disulfide isomerase for ovarian cancer treatment. Proc. Natl. Acad. Sci.
U.S.A. 109, 16348–16353. doi: 10.1073/pnas.1205226109
Yoshimori, T., Semba, T., Takemoto, H., Akagi, S., Yamamoto, A., and Tashiro, Y.
(1990). Protein disulfide-isomerase in rat exocrine pancreatic cells is exported
from the endoplasmic reticulum despite possessing the retention signal. J. Biol.
Chem. 265, 15984–15990.
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 03 June 2014; accepted: 07 August 2014; published online: 26 August 2014.
Citation: Ali Khan H and Mutus B (2014) Protein disulfide isomerase a multifunc-
tional protein with multiple physiological roles. Front. Chem. 2:70. doi: 10.3389/
fchem.2014.00070
This article was submitted to Cellular Biochemistry, a section of the journal Frontiers
in Chemistry.
Copyright © 2014 Ali Khan and Mutus. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use, dis-
tribution or reproduction in other forums is permitted, provided the original author(s)
or licensor are credited and that the original publication in this journal is cited, in
accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.
www.frontiersin.org August 2014 | Volume 2 | Article 70 | 9
